NCT06871072Completed
Telerehabilitation for Multiple Sclerosis
Telerehabilitation for Multiple Sclerosis: Artificial Intelligence vs. Conventional Approaches in Strength Training. A Sin-gle-Blinded Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 19 Sept 2025
Brief summary (registry, in English)
Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system and is a leading cause of disability in young adults. It often produces strength deficits. Exercise has been shown to improve strength, mobility, and quality of life while reducing fatigue. Telerehabilitation offers a convenient, accessible alternative for MS patients. This study explores the use of an AI-powered application for prescribing and monitoring strength exercises, ensuring continuous feedback and adherence. Methods: Randomized clinical trial. Intervention of 3 weekly strength training ses-sions for 20 weeks, patients in the experimental group used the AI application, while patients in the control group followed the conventional method, paper-based exercises with access to videos.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 27 Feb 2025
- Start date
- 1 Apr 2025
- Primary completion date
- 15 Aug 2025
- Lead sponsor
- University of Cadiz
- Diseases
- Multiple sclerosis
- NCT number
- NCT06871072
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 1 Apr 2025 to the primary completion date, 15 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have been regularly performing strength exercises for more than 3 months prior.
- Presence of a relapse and/or treatment with corticosteroids within the four weeks prior to the start of the study.
Other illness
- Moderate/severe cognitive impairment that may interfere with the understanding and/or execution of the study.
- History of alcohol and/or drug abuse.
Other
- Patients with severe comorbidities other than MS that may pose a risk for following the exercise guidelines or for their participation in the study for other reasons.
Who the study is looking for
- Diagnosis of multiple sclerosis according to the McDonald criteria 2017:
- Age between 35 and 60 years.
- Score on the Expanded Disability Status Scale in Multiple Sclerosis by Kurtzke (EDSS) between 2 and 6 points.
- Patients who do not require assistive devices for home mobility.
- Patients with no changes in disease-modifying treatment in the last 3 months.
- Patients who have understood, completed, and signed the informed consent and the study information sheet.
Age in the registry: 35 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Macarena University Hospital Coordinator of this site? Confirm its status | Seville | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.